Saturday 20 Apr 2024
By
main news image

This article first appeared in The Edge Financial Daily on June 15, 2017

Southern Acids (M) Bhd (-ve)
SHARES in Southern Acids (M) Bhd (fundamental: 2.5/3, valuation: 1.4/3) triggered our momentum algorithm yesterday for the first time this year. The counter rose 25 sen or 5.56% to hit its 32-month high of RM4.75 with 156,100 shares traded.

The stock has rallied since June 2, following a commendable financial results for its fourth financial quarter ended March 31, 2017 (4QFY17), followed a final dividend of five sen apiece for the quarter under review.

The company, whose core businesses comprise oleochemical, upstream palm oil as well as healthcare, saw 4QFY17 net profit more than triple to RM16.81 million, from RM4.88 million previously, contributed by all three core divisions. Quarterly revenue, meanwhile, rose 74.29% to RM220.11 million, against RM126.29 million.

For its full FY17, Southern Acids’ net profit near doubled to RM48.65 million, from RM24.87 million in FY16. Revenue rose 47.02% to RM740.09 million, from RM503.41 million the previous year.

      Print
      Text Size
      Share